Year |
Citation |
Score |
2024 |
Boreland AJ, Stillitano AC, Lin HC, Abbo Y, Hart RP, Jiang P, Pang ZP, Rabson AB. Sustained type I interferon signaling after human immunodeficiency virus type 1 infection of human iPSC derived microglia and cerebral organoids. Iscience. 27: 109628. PMID 38628961 DOI: 10.1016/j.isci.2024.109628 |
0.53 |
|
2023 |
Boreland AJ, Stillitano AC, Lin HC, Abbo Y, Hart RP, Jiang P, Pang ZP, Rabson AB. Dysregulated neuroimmune interactions and sustained type I interferon signaling after human immunodeficiency virus type 1 infection of human iPSC derived microglia and cerebral organoids. Biorxiv : the Preprint Server For Biology. PMID 37961371 DOI: 10.1101/2023.10.25.563950 |
0.531 |
|
2023 |
Gabriel R, Boreland AJ, Pang ZP. Whole Cell Patch Clamp Electrophysiology in Human Neuronal Cells. Methods in Molecular Biology (Clifton, N.J.). 2683: 259-273. PMID 37300782 DOI: 10.1007/978-1-0716-3287-1_21 |
0.559 |
|
2021 |
Robles DA, Boreland AJ, Pang ZP, Zahn JD. A Cerebral Organoid Connectivity Apparatus to Model Neuronal Tract Circuitry. Micromachines. 12. PMID 34945423 DOI: 10.3390/mi12121574 |
0.512 |
|
2021 |
Xu R, Boreland AJ, Li X, Erickson C, Jin M, Atkins C, Pang ZP, Daniels BP, Jiang P. Developing human pluripotent stem cell-based cerebral organoids with a controllable microglia ratio for modeling brain development and pathology. Stem Cell Reports. PMID 34297942 DOI: 10.1016/j.stemcr.2021.06.011 |
0.55 |
|
2020 |
Scarnati MS, Boreland AJ, Joel M, Hart RP, Pang ZP. Differential sensitivity of human neurons carrying μ opioid receptor (MOR) N40D variants in response to ethanol. Alcohol (Fayetteville, N.Y.). PMID 32561311 DOI: 10.1016/J.Alcohol.2020.05.004 |
0.401 |
|
2020 |
Xu R, Li X, Boreland AJ, Posyton A, Kwan K, Hart RP, Jiang P. Human iPSC-derived mature microglia retain their identity and functionally integrate in the chimeric mouse brain. Nature Communications. 11: 1577. PMID 32221280 DOI: 10.1038/S41467-020-15411-9 |
0.469 |
|
2018 |
Shah R, Zhu M, Boreland A, Filipp F, Chen S. Abstract 5493: Targeted inhibition of glutaminase in GRM1-expressing melanoma cells inhibits cell proliferation by reducing glutamate bioavailability Cancer Research. 78: 5493-5493. DOI: 10.1158/1538-7445.Am2018-5493 |
0.313 |
|
Show low-probability matches. |